Zenith Technologies, a global enterprise management firm headquartered in Ireland, has appointed Carlos Machado as Serialisation Director to lead the company’s sales, operations, implementation and post project support services in the US.
The appointment comes as the pharmaceutical industry faces the challenge of complying with new legal requirements for the authentication and barcoding of licensed drug products from November 2017 in the US and early 2019 in Europe.
Machado joins Zenith Technologies with significant experience of assisting pharmaceutical manufacturers with track and trace technologies, having worked on more than 75 serialisation projects from both an operations and delivery perspective.
In his former role as Director of Global Operations at an anti-counterfeiting technology provider, Machado helped to pioneer the serialisation concept and define the future of authentication.
Jim Lehane, Director at Zenith Technologies, said: 'Serialisation is a real challenge for our customers and it’s an important time for us to add further expertise to our team. Carlos’ background in track and trace technologies and his knowledge of the implementation challenges pharmaceutical manufacturers face, make him ideally suited to lead our serialisation offering in the US, helping our customers achieve seamless compliance with the new regulations.'
Zenith recently announced a global partnership with software provider SEA Vision to support pharmaceutical companies with the installation and integration of serialisation solutions across drug manufacturing sites.
